Australia
# |
Name |
EPS (Diluted) |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 5.45
|
June 30, 2024 | USD 171.50 | 0.95% |
|
Australia |
|
2 |
USD 0.47
|
June 30, 2024 | USD 7.25 | -0.16% |
|
Australia |
|
3 |
USD 0.08
|
June 30, 2024 | USD 2.33 | 0.29% |
|
Australia |
|
4 |
USD 0.03
|
June 30, 2024 | USD 0.74 | 0.02% |
|
Australia |
|
5 |
USD 0.01
|
Dec. 31, 2023 | USD 18.31 | -0.05% |
|
Australia |
|
6 |
USD 0.01
|
June 30, 2024 | USD 1.23 | 0.02% |
|
Australia |
|
7 |
USD -0.00
|
June 30, 2024 | USD 4.80 | 5.03% |
|
Australia |
|
8 |
USD -0.01
|
June 30, 2024 | USD 0.74 | 0.02% |
|
Australia |
|
9 |
USD -0.02
|
June 30, 2024 | USD 2.04 | -5.56% |
|
Australia |
|
10 |
USD -0.02
|
June 30, 2024 | USD 2.09 | 0.97% |
|
Australia |
|
11 |
USD -0.09
|
June 30, 2024 | USD 1.84 | -3.30% |
|
Australia |
|
12 |
USD -0.10
|
June 30, 2024 | USD 2.34 | -4.83% |
|
Australia |
|
13 |
USD -0.35
|
June 30, 2024 | NA |
|
Australia |
||
14 |
USD -1.14
|
June 30, 2024 | USD 1.67 | 2.45% |
|
Australia |
|
15 |
USD -2.94
|
Dec. 31, 2023 | USD 6.22 | 1.04% |
|
Australia |
The Clinical Trials company in Australia with the highest EPS (Diluted) is CSL Limited (ASX: CSL.AX) at USD 5.45.
The Clinical Trials company in Australia with the lowest EPS (Diluted) is Anteris Technologies Ltd (ASX: AVR.AX) at USD -2.94.
The top 10 Clinical Trials companies in Australia by EPS (Diluted) are CSL Limited, Clinuvel Pharmaceuticals Limited, Australian Clinical Labs Limited, Cogstate Limited, Telix Pharmaceuticals Limited, PolyNovo Limited, Alterity Therapeutics Limited, Monash IVF Group Limited, Immuron Limited and Immutep Limited.
The bottom 10 Clinical Trials companies in Australia by EPS (Diluted) are Anteris Technologies Ltd, Incannex Healthcare Limited, Opthea Limited, Clarity Pharmaceuticals Ltd, Mesoblast Limited, Immutep Limited, Immuron Limited, Monash IVF Group Limited, Alterity Therapeutics Limited and PolyNovo Limited.